A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetesVeeral Ajmera, Rohit Loomba, Sandra Cepin et al.|Journal of Hepatology|2022Cited by 310
Disparities for Hispanic Adults With Metabolic Dysfunction-associated Steatotic Liver Disease in the United States: A Systematic Review and Meta-analysisKaleb Tesfai, Rohit Loomba, Jordan Pace et al.|Clinical Gastroenterology and Hepatology|2024Cited by 42
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetesVeeral Ajmera, Rohit Loomba, Ricki Bettencourt et al.|Hepatology|2023Cited by 30
A Prospective Study on the Prevalence of <scp>MASLD</scp> in Patients With Type 2 Diabetes and HyperferritinaemiaMaral Amangurbanova, Rohit Loomba, Daniel Q. Huang et al.|Alimentary Pharmacology & Therapeutics|2024Cited by 22
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetesLana Bridi, Veeral Ajmera, Saaket Agrawal et al.|Alimentary Pharmacology & Therapeutics|2024Cited by 21